4-(1H-pyrrol-1-yl) imidazoles with angiotension II antagonist activity
AssigneeWarner-Lambert Company
InventorsJohn C. Hodges, John G. Topliss
Life of this patent
Estimating the term…
Abstract
Novel substituted 4-(1-H-pyrrol-1-yl)imidazoles are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and methods of using them. Novel intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, glaucoma, vascular smooth muscle proliferation associated with atherosclerosis, and with postsurgical vascular restenosis.
Claims1
A compound selected from
- 4-amino-2-butyl-5-cyanoimidazole,
- 4-amino-5-cyano-2-propylimidazole,
- 2-butyl-5-cyano-4-(1H-pyrrol-1-yl)imidazole,
- 5-cyano-2-propyl-4-(1H-pyrrol-1-yl)imidazole,
- ethyl 2-butyl-4-(1H-pyrrol-1-yl)imidazole-5-carboxylate,
- methyl 2-butyl-4-(1H-pyrrol-1-yl)imidazole, 2-butyl-5-(hydroxymethyl)-4-(1H-pyrrol-1-yl)imidazole-5-carboxylate,
- 5-cyano-4-[2-(1-oxo-2,2,2-trifluoroethyl)-1H-pyrrol-1-yl]-2-propylimidazole
- methyl 1-(5-cyano-2-propylimidazol-4-yl)1H-pyrrole-2-carboxylate,
- 5-cyano-4-(2,5-dichloro-1H-pyrrol-1-yl)-2-propylimidazole,
- methyl 4-[2-(1-oxo-2,2,2-trifluoroethyl)-1H-pyrrol-1-yl]-2-propylimidazole-5-carb oxylate,
- methyl 2-butyl-4-[2-(1-oxo-2,2,2-trifluoroethyl)-1H-pyrrol-1-yl]imidazole-5-carbo xylate,
- 5-cyano-4-(2,5-dichloro-1H-pyrrol-1-yl)-2-propylimidazole,
- methyl 2-cyclopropyl-4-(2,5-dimethyl-1H-pyrrol-1-yl)-imidazole-5-carboxylate,
- methyl 4-(2-methyl-5-propyl-1H-pyrrol-1-yl)-2-propylimidazole-5-carboxylate,
- 4-(2,5-dimethyl-1H-pyrrol-1-yl)-2-propylimidazole-5-carboxaldehyde,
- methyl 4-(3-carboxyethyl-1H-pyrrol-1-yl)-2-propylimidazole-5-carboxylate,
- methyl 4-(2,5-dimethyl-1H-pyrrol-1-yl)-2-propylimidazole-5-carboxylate,
- 2-propyl-4-(1H-pyrrol-1-yl)-imidazole-5-carboxaldehyde,
- 5-(hydroxymethyl)-2 propyl-4-(1H-pyrrol-1-yl)imidazole,
- 2-butyl-5-(hydroxymethyl)-4-(1H-pyrrol-1-yl)imidazole,
- 5-cyano-4-(2,5-dimethyl-1H-pyrrol-1-yl)-2-propylimidazole,
- methyl 4-(2-methyl-3-carboxymethyl-1H-pyrrol-1-yl)-2-propylimidazole-5-carboxylat e,
- methyl 2-butyl-4-[2-(1-oxo-2,2,2-trifluoroethyl)-1H-pyrrol-1-yl]imidazole-5-carbo xylate,
- methyl 2-propyl-4-(2,5-dichloro-1H-pyrrol-1-yl)imidazole-5-carboxylate,
- 5-(hydroxymethyl)-2-propyl-4-(1H-pyrrol-1-yl)imidazole,
- methyl 4-amino-2-cyclopropylimidazole-5-carboxylate,
- 5-(hydroxymethyl)-2-propyl-4-(2,5-dimethyl-1H-pyrrol-1-yl)imidazole, and
- methyl (E)-3-[4-(2,5-dimethyl-1H-pyrrol-1-yl)-2-propylimidazol-5-yl]-2-propenoic acid.
Dependencies are inferred from the claim text.